A young singer’s death following a snakebite in Nigeria’s capital has ignited a national debate over the chronic shortages of life-saving antivenoms and the systemic failures plaguing emergency healthcare.
Ifunanya Nwangene, a 26-year-old vocalist known as Nanyah, was bitten by a snake in her Abuja apartment. Despite being rushed to medical facilities, she succumbed to her injuries within hours. Reports indicate that a frantic search for the correct medication at a local pharmacy occurred as she lay dying in a hospital bed.
Her death underscores a grim global statistic: snakebites claim a life approximately every five minutes. The World Health Organization classifies snakebite envenoming as a neglected tropical disease and stresses that fatalities are largely preventable with timely access to safe, effective antivenom, which is listed as an essential medicine.
In Nigeria, which is home to numerous venomous snake species, healthcare workers frequently report critical shortages of these vital drugs. A recent international survey of medical personnel highlighted that over a third face daily antivenom stockouts, compounded by a lack of specialized training and inadequate medical infrastructure.
While the hospital where Nwangene ultimately died has stated it had the necessary antivenom and provided appropriate care, the circumstances of her death have fueled public outrage and questions about accountability. Friends and colleagues have shared accounts of being sent to procure additional drugs externally during the emergency.
Health advocates are calling for urgent political will and increased investment to address what they term a “preventable yet devastating” crisis. They argue that overcoming snakebite fatalities requires concrete action and sustained funding, moving beyond sympathy to implement scalable solutions within primary healthcare systems where these incidents occur.
